http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008049645-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d82de571f8a6ea172282c760db461f54 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate | 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b480fdb46032eb32f603dedf98848bf |
| publicationDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2008049645-A3 |
| titleOfInvention | Hydrates of erlotinib hydrochloride |
| abstract | The invention relates to a crystalline erlotinib hydrochloride hydrate and to a process for making crystalline erlotinib anhydrate, which comprises crystallizing an erlotinib hydrochloride hydrate from an aqueous solution of erlotinib hydrochloride; and recrystallizing said erlotinib hydrochloride hydrate from a non-aqueous solvent system to form an anhydrous erlotinib hydrochloride of Form A, Form B, or Form E. |
| priorityDate | 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.